Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity.
about
Succinate Dehydrogenase Loss in Familial Paraganglioma: Biochemistry, Genetics, and EpigeneticsRare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma.Molecular markers of paragangliomas/pheochromocytomasMitochondrial Deficiencies in the Predisposition to ParagangliomaCurrent approaches and recent developments in the management of head and neck paragangliomas.Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene.Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated geneComprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas.Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas.Vascular pattern analysis for the prediction of clinical behaviour in pheochromocytomas and paragangliomas.Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis.Pheochromocytoma and paraganglioma in cyanotic congenital heart disease.APOBEC3A cytidine deaminase induces RNA editing in monocytes and macrophagesDeciphering the molecular basis of invasiveness in Sdhb-deficient cells.HRAS mutation prevalence and associated expression patterns in pheochromocytoma.Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas.Identification of eight novel SDHB, SDHC, SDHD germline variants in Danish pheochromocytoma/paraganglioma patients.(68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity.Phenylethanolamine N-methyltransferase downregulation is associated with malignant pheochromocytoma/paraganglioma.Complex role of HIF in cancer: the known, the unknown, and the unexpected.Global DNA Methylation Analysis Identifies Two Discrete clusters of Pheochromocytoma with Distinct Genomic and Genetic Alterations.Role of (18) F-FDOPA PET/CT imaging in endocrinology.Paraganglioma and phaeochromocytoma: from genetics to personalized medicine.Toward an improved definition of the genetic and tumor spectrum associated with SDH germ-line mutations.Mitochondrial reactive oxygen species and cancer.Malignant pheochromocytomas/paragangliomas harbor mutations in transport and cell adhesion genes.Update on Modern Management of Pheochromocytoma and Paraganglioma.Metformin Suppresses Proliferation and Viability of Rat Pheochromocytoma Cells.PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics.The Penetrance of Paraganglioma and Pheochromocytoma in SDHB germline mutation carriers.The RET E616Q Variant is a Gain of Function Mutation Present in a Family with Features of Multiple Endocrine Neoplasia 2A.Precision medicine in pheochromocytoma and paraganglioma: current and future concepts.Neuroendocrine Tumors of the Urinary Bladder According to the 2016 World Health Organization Classification: Molecular and Clinical Characteristics.Characteristics of Pediatric vs Adult Pheochromocytomas and Paragangliomas.Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas.Long clinical benefit achieved in two patients with malignant paraganglioma treated by metronomic cyclophosphamide.Pheochromocytomas and paragangliomas in humans and dogs.Current perioperative management of pheochromocytomas.Surgical approaches in hereditary endocrine tumors.
P2860
Q26796203-9E4BCE2D-88B6-4A0D-908E-7CDE5307EFFEQ33570108-C99CCA9C-C318-4C78-9E73-0889471B0E2DQ33649025-616A6A6B-3919-4EB6-9DA4-E267DB7B2C79Q33844924-287857A5-7773-4480-B0F4-A756BA813580Q34204524-01FAC9B6-6C09-4905-A2AB-11EB88B00C65Q34466932-3AC2E6AE-6321-45C5-9AB9-27F50FFE85B7Q34478820-B0DCA5E7-81AE-474F-B036-9213B098D05BQ34680693-6C7AF357-5569-43B8-B072-99E5F0CAEAD4Q34998940-E150043F-EA2D-419B-9172-0DABF4EC4A03Q35160825-D7437B9E-7A88-4894-B7CE-F01C5D3E0BF1Q35203161-42C80D5D-BC38-45CF-846F-B4C336333C47Q35323457-EAA5CC9F-71BB-4E3B-8931-FC6169EEC33FQ35441891-0B5A2D56-3301-4AC1-8FDB-340155264D3FQ35543248-95739948-F284-4204-945B-40F37A20281EQ36545038-CE487067-7E78-4F6F-A227-4B24B621EED3Q36694372-D94F2D9C-5185-4770-BC6C-040034C6A987Q36863246-AC6EB7A3-40D7-46FC-9C70-19D3B6EE643CQ36982205-785DC1C3-60CC-4B7D-9693-56B47C77116DQ37185143-D6CA9224-EBD0-41DF-9FCB-9F0F3FD8F199Q37269244-88992F05-4D4D-47B4-8292-D86B59C5ADD4Q37301016-D3F0CC48-4AD8-4E6F-9D9D-BF868C2CF824Q37714945-8D3B3FC5-9478-4327-B568-E7C99C824BD3Q38233342-3D025232-1AEB-4A87-823A-FE60D18F86E3Q38266745-847438C2-2A6D-4188-BF1A-6169EC7DFA28Q38267933-9DC64E85-124F-4622-A725-E4A7404518AFQ38351698-28613CCD-F34C-4F84-9012-11F5FD2A30EBQ38453834-DB4A929F-FC26-4B53-B86A-E0D3342A741CQ38661522-3D4CCE49-CBA0-49E3-BE62-51EDE81652B9Q38662959-0E965C03-91DB-48D0-BB3A-F4396821A52FQ38759395-202B55E8-7447-43F2-A26A-593F9DBD6324Q38786536-B26B8062-53E8-47D5-8445-A5A1656B05AEQ38814755-FF5C86DB-B121-4B80-BF7B-DBC88B5E29D4Q38831451-C0D4ACDC-9EDA-4B75-A21B-47401A3D7193Q38849534-31B89380-F175-4AB0-8B8E-47720EA5F03EQ38890111-163528B6-F74E-4308-AD14-FC9506E016B6Q39011468-068A486F-0ACA-4542-AA53-112985649227Q39084619-BA96733F-A175-4F7E-902A-A64163187C1EQ39102360-A53A08BD-2437-4268-BE94-7F0B25433E23Q39135536-F1B5F9E8-BF7B-4DC6-B176-76633B71F225Q39271803-3E867362-0B6F-4D80-A8AF-5E71E3608FD7
P2860
Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity.
@en
type
label
Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity.
@en
prefLabel
Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity.
@en
P356
P1476
Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity.
@en
P2093
Patricia L M Dahia
P2888
P304
P356
10.1038/NRC3648
P407
P577
2014-01-20T00:00:00Z
P6179
1015817045